Congratulations to Exact Sciences

Congratulations to Exact Sciences

The New England Journal of Medicine has published an article concerning Cologuard  the new test developed by our client Exact Sciences.

 It shows that in a 10,500 82 site nationwide study that this non-invasive test found 92% of cancer and more than half of the pre-cancer larger than 2 centimeters.

On March 26, Cologuard will be reviewed by an Advisory Committee of the FDA.

Congratulations to Kevin Conroy and his team!

Leave a Reply

Your email address will not be published. Required fields are marked *